UniProtKB/Swiss-Prot P35916: Variant p.Thr494Ala

Vascular endothelial growth factor receptor 3
Gene: FLT4
Feedback?

Variant information Variant position:

494 The position of the amino-acid change on the UniProtKB canonical protein sequence.
Type of variant:

LB/B The variants are classified into three categories: LP/P, LB/B and US.

LP/P: likely pathogenic or pathogenic.
LB/B: likely benign or benign.
US: uncertain significance

Residue change:

From Threonine (T) to Alanine (A) at position 494 (T494A, p.Thr494Ala). Indicates the amino acid change of the variant. The one-letter and three-letter codes for amino acids used in UniProtKB/Swiss-Prot are those adopted by the commission on Biochemical Nomenclature of the IUPAC-IUB.
Physico-chemical properties:

Change from medium size and polar (T) to small size and hydrophobic (A) The physico-chemical property of the reference and variant residues and the change implicated.
BLOSUM score:

0 The score within a Blosum matrix for the corresponding wild-type to variant amino acid change. The log-odds score measures the logarithm for the ratio of the likelihood of two amino acids appearing by chance. The Blosum62 substitution matrix is used. This substitution matrix contains scores for all possible exchanges of one amino acid with another:

Lowest score: -4 (low probability of substitution).
Highest score: 11 (high probability of substitution).

More information can be found on the following page
Other resources:

Links to websites of interest for the variant.

Variant rs307826 [ dbSNP | Ensembl ]

Sequence information Variant position:

494 The position of the amino-acid change on the UniProtKB canonical protein sequence.
Protein sequence length:

1363 The length of the canonical sequence.
Location on the sequence:

LRRRQQQDLMPQCRDWRAVT T QDAVNPIESLDTWTEFVEGK The residue change on the sequence. Unless the variant is located at the beginning or at the end of the protein sequence, both residues upstream (20) and downstream (20) of the variant will be shown.
Residue conservation:

The multiple alignment of the region surrounding the variant against various orthologous sequences.

Human                         LRRRQQQDLMPQCRDWRAVTTQDAVNPIESLDTWTEFVEGK

Mouse                         LRRRQQRDGMPQCRDWKEVTTQDAVNPIESLDSWTEFVEGK

Rat                           LRRRQPRDGMPQCRDWKEVTTQDAVNPIESLDTWTESVEGK

Zebrafish                     LRRRGGRDQSPFCHNWMDLDPEHAVNPIESIDTLTQMVDGK

Sequence annotation in neighborhood:

The regions or sites of interest surrounding the variant. In general the features listed are posttranslational modifications, binding sites, enzyme active sites, local secondary structure or other characteristics reported in the cited references. The "Sequence annotation in neighborhood" lines have a fixed format:

Type: the type of sequence feature.
Positions: endpoints of the sequence feature.
Description: contains additional information about the feature.

Type	Positions	Description
Chain	25 – 1363	Vascular endothelial growth factor receptor 3
Topological domain	25 – 775	Extracellular
Domain	422 – 552	Ig-like C2-type 5
Disulfide bond	445 – 534

Literature citations
Somatic mutation of vascular endothelial growth factor receptors in juvenile hemangioma.
Walter J.W.; North P.E.; Waner M.; Mizeracki A.; Blei F.; Walker J.W.T.; Reinisch J.F.; Marchuk D.A.;
Genes Chromosomes Cancer 33:295-303(2002)
Cited for: VARIANTS HCI SER-954 AND SER-1137; VARIANTS ALA-494; GLN-890 AND HIS-1146; Patterns of somatic mutation in human cancer genomes.
Greenman C.; Stephens P.; Smith R.; Dalgliesh G.L.; Hunter C.; Bignell G.; Davies H.; Teague J.; Butler A.; Stevens C.; Edkins S.; O'Meara S.; Vastrik I.; Schmidt E.E.; Avis T.; Barthorpe S.; Bhamra G.; Buck G.; Choudhury B.; Clements J.; Cole J.; Dicks E.; Forbes S.; Gray K.; Halliday K.; Harrison R.; Hills K.; Hinton J.; Jenkinson A.; Jones D.; Menzies A.; Mironenko T.; Perry J.; Raine K.; Richardson D.; Shepherd R.; Small A.; Tofts C.; Varian J.; Webb T.; West S.; Widaa S.; Yates A.; Cahill D.P.; Louis D.N.; Goldstraw P.; Nicholson A.G.; Brasseur F.; Looijenga L.; Weber B.L.; Chiew Y.-E.; DeFazio A.; Greaves M.F.; Green A.R.; Campbell P.; Birney E.; Easton D.F.; Chenevix-Trench G.; Tan M.-H.; Khoo S.K.; Teh B.T.; Yuen S.T.; Leung S.Y.; Wooster R.; Futreal P.A.; Stratton M.R.;
Nature 446:153-158(2007)
Cited for: VARIANTS [LARGE SCALE ANALYSIS] ASP-149; CYS-378; ALA-494; SER-527; SER-641; TYR-868; ILE-1010; GLN-1031; ASN-1049; GLN-1075 AND HIS-1146;

Disclaimer: Any medical or genetic information present in this entry is provided for research, educational and informational purposes only. They are not in any way intended to be used as a substitute for professional medical advice, diagnostic, treatment or care.